Academic Journals Database
Disseminating quality controlled scientific knowledge

Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats

ADD TO MY LIST
 
Author(s): Runfola Matteo | Rossi Simone | Panunzi Simona | Spada Pier | Gui Daniele

Journal: BMC Gastroenterology
ISSN 1471-230X

Volume: 3;
Issue: 1;
Start page: 26;
Date: 2003;
Original page

ABSTRACT
Abstract Background Botulinum toxin blocks acetylcholine release from nerve endings and acts as a long term, reversible inhibitor of muscle contraction as well as of salivary, sweat gland, adrenal and prostatic secretions. The aim of the present study is to investigate whether gastric submucosal injection of botulinum toxin type A reduces stimulated gastric production of HCl. Methods Sixty-four rats were randomized in two groups and laparotomized. One group was treated with botulinum toxin-A 10 U by multiple submucosal gastric injections, while the second group was injected with saline. Two weeks later, acid secretion was stimulated by pyloric ligation and acid output was measured. Body weight, food and water intake were also recorded daily. Results HCl production after pyloric ligation was found to be significantly lower in botulinum toxin-treated rats (657 ± 90.25 micromol HCl vs. 1247 ± 152. P = 0.0017). Botulinum toxin-treated rats also showed significantly lower food intake and weight gain. Conclusions Botulinum toxin type A reduces stimulated gastric acidity. This is likely due either to inhibition of the cholinergic stimulation of gastric parietal cells, or to an action on the myenteric nervous plexuses. Reduction of growth and food intake may reflect both impaired digestion and decreased gastric motility.

Tango Jona
Tangokurs Rapperswil-Jona

     Save time & money - Smart Internet Solutions